Our data also found that the expression of BTG4 is downregulated in lung and colon cancers, and overexpression of BTG4 can inhibit proliferation and migration, and induce apoptosis, suggesting that similar to BTG2 and BTG3, BTG4 might also act as a potential tumor suppressor. Here, BTG3 is linked to neoplasm.